These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1964991)
1. [Studies of the adaptation of influenza viruses to lowered temperatures of replication. II. Studies in vivo]. Brydak L; Sadowski W Med Dosw Mikrobiol; 1990; 42(1-2):50-3. PubMed ID: 1964991 [TBL] [Abstract][Full Text] [Related]
2. [Studies of adaptation of influenza viruses to their replication in low temperature. I. Biological properties]. Brydak L Med Dosw Mikrobiol; 1990; 42(3-4):122-30. PubMed ID: 2084448 [TBL] [Abstract][Full Text] [Related]
3. Studies on pathogenicity and immunogenicity of cold adapted variants of influenza virus. Brydak L Acta Microbiol Pol; 1982; 31(3-4):287-92. PubMed ID: 6189378 [TBL] [Abstract][Full Text] [Related]
4. Studies on the adaptation of influenza virus replicated at low temperature. III. Biochemical studies. Brydak L Acta Microbiol Pol; 1990; 39(1-2):59-70. PubMed ID: 1715640 [TBL] [Abstract][Full Text] [Related]
5. The influence of endogenous hypocorticism on the replication of influenza virus in the mouse lungs and the production of specific antibodies. Semenkov VF; Levina LV; Lavrov VF; Ageeva ON Acta Virol; 1990 Feb; 34(1):37-43. PubMed ID: 1975723 [TBL] [Abstract][Full Text] [Related]
6. [Biological relations of selected influenza virus strains adapted to mouse lungs. I. H3N2 influenza virus study]. Nabi N; Maksimova-Todorova V; Gegova G; Manolova N Acta Microbiol Bulg; 1980; 6():42-7. PubMed ID: 7340409 [No Abstract] [Full Text] [Related]
7. Peculiarities of influenza infection caused by highly and poorly immunogenic strains of influenza virus. Frolov AF; Skripchenko GS; Shcherbinskaya AM; Vlasova AG; Rybakova TM J Hyg Epidemiol Microbiol Immunol; 1984; 29(3):303-9. PubMed ID: 6544322 [TBL] [Abstract][Full Text] [Related]
8. Studies on adaptation of influenza virus replicated at low temperature.IV. Sensitivity of neuraminidase and hemagglutinin to some proteolytic enzymes, detergents and chemical agents. Brydak L Acta Microbiol Pol; 1990; 39(3-4):137-47. PubMed ID: 1715648 [TBL] [Abstract][Full Text] [Related]
9. Pathogenicity, immunogenicity and genetic stability in mice and ferrets of a cold inhibitor-resistant mutant of influenza H3N2 virus. Závadová H; Stárek M; Dolezalová B; Vonka V Dev Biol Stand; 1976; 33():151-4. PubMed ID: 955266 [TBL] [Abstract][Full Text] [Related]
10. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703 [TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a live attenuated influenza B virus vaccine candidate. Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290 [TBL] [Abstract][Full Text] [Related]
12. Experimental studies on influenza A2 virus infection after peroral inoculation. Sidorova LA; Alekseyeva AK Acta Virol; 1973 Jul; 17(4):293-7. PubMed ID: 4148208 [No Abstract] [Full Text] [Related]
13. [Reproduction and immunogenic properties of recombinant and parent strains of influenza virus]. Zgorzelska K; Semkow R Med Dosw Mikrobiol; 1981; 33(2):115-8. PubMed ID: 6170847 [No Abstract] [Full Text] [Related]
14. Studies on the adaptation of influenza virus replicated at low temperature. V. Isoelectric focusing studies. Brydak L Acta Microbiol Pol; 1993; 42(1):29-33. PubMed ID: 7504872 [TBL] [Abstract][Full Text] [Related]
15. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide. Kostolanský F; Mucha V; Slováková R; Varecková E Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859 [TBL] [Abstract][Full Text] [Related]
16. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Brett IC; Johansson BE Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702 [TBL] [Abstract][Full Text] [Related]
17. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167 [TBL] [Abstract][Full Text] [Related]
18. Interferon and humoral immune response in experimental influenza. I. Infection with virus unadapted to the mouse. Szalaty H; Szulc B Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):503-8. PubMed ID: 749803 [TBL] [Abstract][Full Text] [Related]
19. Protection of mice with recombinant influenza virus neuraminidase. Kilbourne ED; Pokorny BA; Johansson B; Brett I; Milev Y; Matthews JT J Infect Dis; 2004 Feb; 189(3):459-61. PubMed ID: 14745703 [TBL] [Abstract][Full Text] [Related]
20. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection. Mozdzanowska K; Maiese K; Furchner M; Gerhard W Virology; 1999 Feb; 254(1):138-46. PubMed ID: 9927581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]